Peregrine Pharmaceuticals Inc. (PPHM)
(Real Time Quote from BATS)
$4.22 USD
+0.03 (0.72%)
Updated Jan 5, 2018 04:00 PM ET
NA Value
NA Growth NA Momentum NA VGMBrokerage Reports
0 items in cart
Avid Bioservices, Inc. [PPHM]
Reports for Purchase
Showing records 1 - 20 ( 131 total )
Company: Avid Bioservices, Inc.
Industry: Medical - Biomedical and Genetics
ValuEngine Detailed Valuation Report for PPHM
Provider: ValuEngine, Inc
Company: Avid Bioservices, Inc.
Industry: Medical - Biomedical and Genetics
We are dropping coverage due to the departure of the covering analyst.
Provider: Roth Capital Partners, Inc.
Company: Avid Bioservices, Inc.
Industry: Medical - Biomedical and Genetics
Healthcare: Inaugural Healthcare Monthly; Catalysts Galore
Provider: Roth Capital Partners, Inc.
Analyst: PANTGINIS J
Company: Avid Bioservices, Inc.
Industry: Medical - Biomedical and Genetics
MID-DAY SUMMARY
Provider: Roth Capital Partners, Inc.
Company: Avid Bioservices, Inc.
Industry: Medical - Biomedical and Genetics
F1Q17 Results; Build It and They Will Come; Expanding Services
Provider: Roth Capital Partners, Inc.
Analyst: PANTGINIS J
Company: Avid Bioservices, Inc.
Industry: Medical - Biomedical and Genetics
MORNING SUMMARY
Provider: Roth Capital Partners, Inc.
Company: Avid Bioservices, Inc.
Industry: Medical - Biomedical and Genetics
F2016 Results; Avid in Front; Bavi a Science Experiment Again
Provider: Roth Capital Partners, Inc.
Analyst: PANTGINIS J
Company: Avid Bioservices, Inc.
Industry: Medical - Biomedical and Genetics
MORNING SUMMARY
Provider: Roth Capital Partners, Inc.
Company: Avid Bioservices, Inc.
Industry: Medical - Biomedical and Genetics
F3Q16 Results; Driving Avid Revenue While I-O Program Being Redefined
Provider: Roth Capital Partners, Inc.
Analyst: PANTGINIS J
Company: Avid Bioservices, Inc.
Industry: Medical - Biomedical and Genetics
MORNING SUMMARY
Provider: Roth Capital Partners, Inc.
Company: Avid Bioservices, Inc.
Industry: Medical - Biomedical and Genetics
Kick in the Gut for Bavi; Downgrade to Neutral, $0.50 Target
Provider: Roth Capital Partners, Inc.
Analyst: PANTGINIS J
Company: Avid Bioservices, Inc.
Industry: Medical - Biomedical and Genetics
MORNING SUMMARY
Provider: Roth Capital Partners, Inc.
Company: Avid Bioservices, Inc.
Industry: Medical - Biomedical and Genetics
A Year of Strategic Moves and Likely Pivotal Data
Provider: Roth Capital Partners, Inc.
Analyst: PANTGINIS J
Company: Avid Bioservices, Inc.
Industry: Medical - Biomedical and Genetics
MORNING SUMMARY
Provider: Roth Capital Partners, Inc.
Company: Avid Bioservices, Inc.
Industry: Medical - Biomedical and Genetics
F2Q16 Results: SUNRISE Almost Enrolled; Trials Expanding; Tweaking PT to $3
Provider: Roth Capital Partners, Inc.
Analyst: PANTGINIS J
Company: Avid Bioservices, Inc.
Industry: Medical - Biomedical and Genetics
MID-DAY SUMMARY
Provider: Roth Capital Partners, Inc.
Company: Avid Bioservices, Inc.
Industry: Medical - Biomedical and Genetics
F1Q16 Results; Looking To Combo Study Starts
Provider: Roth Capital Partners, Inc.
Analyst: PANTGINIS J
Company: Avid Bioservices, Inc.
Industry: Medical - Biomedical and Genetics
MORNING SUMMARY
Provider: Roth Capital Partners, Inc.
Company: Avid Bioservices, Inc.
Industry: Medical - Biomedical and Genetics
Company: Avid Bioservices, Inc.
Industry: Medical - Biomedical and Genetics
MORNING SUMMARY
Provider: Roth Capital Partners, Inc.